Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia ; volume:11 ; number:1 ; day:16 ; month:11 ; year:2022 ; pages:1-15 ; date:12.2022
Experimental hematology & oncology ; 11, Heft 1 (16.11.2022), 1-15, 12.2022
- Urheber
-
Zhou, Weijun
Yu, Jinyi
Li, Yilu
Wang, Kankan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-022-00353-3
- URN
-
urn:nbn:de:101:1-2023012909135631638459
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhou, Weijun
- Yu, Jinyi
- Li, Yilu
- Wang, Kankan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Next-Generation TCR-transgenic T cells for Immunotherapy
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Next-Generation TCR-transgenic T cells for Immunotherapy
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Natural killer cell-based immunotherapy for acute myeloid leukemia
Neoantigen vaccine: an emerging tumor immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
TCR-like antibodies in cancer immunotherapy
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
CD8+ T cell-based cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency